Poor internal communication hindered FDA’s response to crisis, former deputy commissioner says in congressional testimony
Tags: Abbott LaboratoriesABTBabyFormulaC&E Industry News FiltercapacityCapacity/Facilitiesconsumer safetyContent TypescorporateCorporate/Industrial NewsExFDAfacilitiesFactiva FiltersFrank Yiannasgovernment policyhealthcareHealthcare/Life Sciencesindustrial newsIndustrylife sciencesOfficialoutputOutput/ProductionPharmaceuticalsproblemsproductProduct RecallsProduct ShortageProduct/Consumer SafetyproductionproductsProducts/ServicesregulationRegulation/Government PolicyremainsservicesSYNDvulnerableWSJ-PRO-WSJ.com